Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;


           Compensatory Arrangements of Certain Officers.




On July 2, 2022, Tivity Health, Inc. (the "Company") entered into a Separation
and Consulting Agreement and General Release (the "Separation Agreement") with
Adam Holland, Chief Financial Officer of the Company, which provided for the
termination of Mr. Holland's employment with the Company. The Separation
Agreement also provides that Mr. Holland will receive those separation payments
and benefits that he is entitled to receive under his employment agreement in
respect of a termination without cause, which agreement has previously been
disclosed. Mr. Holland will provide consulting services to the Company for a
period of 30 days in order to facilitate the transition to his successor and
will receive a consulting fee of $36,500 for providing such consulting services.




--------------------------------------------------------------------------------

© Edgar Online, source Glimpses